From: Coresidence increases the risk of testing positive for COVID-19 among older Brazilians
 | Testing (M1) | Testing (M2) | Positive (M1) | Positive (M2) | ||||
---|---|---|---|---|---|---|---|---|
PR | 95% CI | PR | 95% CI | PR | 95% CI | PR | 95% CI | |
Fixed | ||||||||
 Living arrangement (versus older adult alone) | ||||||||
  Older adults only | 0.921 | (0.83, 1.02) | 0.902* | (0.81, 1.00) | 1.021 | (0.81, 1.29) | 1.012 | (0.80, 1.29) |
  Multigenerational | 0.821*** | (0.73, 0.92) | 0.799*** | (0.71, 0.90) | 1.522** | (1.16, 2.00) | 1.506** | (1.14, 2.00) |
  Skipped generation | 0.743** | (0.61, 0.90) | 0.721** | (0.59, 0.88) | 1.634* | (1.06, 2.51) | 1.587* | (1.02, 2.48) |
 Adults and older adults | 0.955 | (0.87, 1.05) | 0.930 | (0.84, 1.02) | 1.292* | (1.03, 1.63) | 1.265 | (1.00, 1.60) |
  Symptoms | 1.734*** | (1.68, 1.79) | 1.472*** | (1.37, 1.58) | 2.357*** | (2.21, 2.52) | 2.133*** | (1.82, 2.50) |
 Interactions | ||||||||
  Symptoms*older adults only |  |  | 1.164** | (1.06, 1.28) |  |  | 1.064 | (0.87, 1.30) |
  Symptoms*Multigenerational |  |  | 1.243*** | (1.12, 1.38) |  |  | 1.078 | (0.87, 1.33) |
  Symptoms*Skipped generation |  |  | 1.281* | (1.05, 1.56) |  |  | 1.184 | (0.89, 1.58) |
  Symptoms*Adults and older adults |  |  | 1.250*** | (1.15, 1.36) |  |  | 1.170 | (0.98, 1.40) |
 Age (in years) | 0.984*** | (0.98, 0.99) | 0.984*** | (0.98, 0.99) | 0.976*** | (0.97, 0.99) | 0.976*** | (0.97, 0.99) |
 Female (versus male) | 0.911** | (0.85, 0.97) | 0.911** | (0.85, 0.97) | 0.882 | (0.76, 1.03) | 0.882 | (0.76, 1.03) |
 Race (versus White) | ||||||||
  Black | 0.946 | (0.84, 1.07) | 0.946 | (0.84, 1.07) | 0.931 | (0.71, 1.23) | 0.931 | (0.71, 1.23) |
  Brown | 0.925* | (0.86, 0.99) | 0.925* | (0.86, 0.99) | 1.129 | (0.96, 1.33) | 1.129 | (0.96, 1.33) |
  Indigenous | 1.780** | (1.19, 2.67) | 1.778** | (1.18, 2.67) | 1.783 | (0.49, 6.48) | 1.784 | (0.49, 6.48) |
 Other | 0.938 | (0.69, 1.27) | 0.938 | (0.69, 1.27) | 0.503 | (0.23, 1.11) | 0.503 | (0.23, 1.11) |
 Education (versus no schooling) | ||||||||
  Less than high school | 1.081 | (0.98, 1.20) | 1.080 | (0.97, 1.20) | 1.201 | (0.97, 1.48) | 1.200 | (0.97, 1.48) |
  High school complete | 1.576*** | (1.40, 1.78) | 1.574*** | (1.40, 1.77) | 1.948*** | (1.49, 2.54) | 1.945*** | (1.49, 2.54) |
  College or more | 2.558*** | (2.26, 2.89) | 2.556*** | (2.26, 2.89) | 2.536*** | (1.85, 3.47) | 2.534*** | (1.85, 3.47) |
 Per capita household quartile (versus 1st) | ||||||||
  2 | 1.033 | (0.97, 1.09) | 1.033 | (0.97, 1.09) | 1.088 | (0.96, 1.23) | 1.087 | (0.96, 1.23) |
  3 | 1.179*** | (1.10, 1.26) | 1.178*** | (1.10, 1.26) | 1.264** | (1.09, 1.46) | 1.264** | (1.09, 1.46) |
  4 | 1.469*** | (1.37, 1.58) | 1.469*** | (1.37, 1.58) | 1.558*** | (1.32, 1.83) | 1.554*** | (1.32, 1.83) |
 Region (versus North) | ||||||||
  Northeast | 0.825*** | (0.74, 0.92) | 0.825*** | (0.74, 0.92) | 0.369*** | (0.26, 0.51) | 0.369*** | (0.26, 0.51) |
  Southeast | 0.442*** | (0.39, 0.49) | 0.442*** | (0.39, 0.49) | 0.123*** | (0.09, 0.17) | 0.123*** | (0.09, 0.17) |
  South | 0.348*** | (0.31, 0.40) | 0.349*** | (0.31, 0.40) | 0.0846*** | (0.06, 0.12) | 0.0847*** | (0.06, 0.12) |
  Center West | 0.948 | (0.84, 1.07) | 0.948 | (0.84, 1.07) | 0.479*** | (0.32, 0.71) | 0.479*** | (0.32, 0.71) |
 Urban (versus rural) | 2.458*** | (2.22, 2.73) | 2.457*** | (2.22, 2.72) | 2.333*** | (1.93, 2.82) | 2.332*** | (1.93, 2.82) |
 Health conditions (versus none) | ||||||||
  Diabetes | 1.214*** | (1.14, 1.29) | 1.213*** | (1.14, 1.29) | 1.478*** | (1.28, 1.71) | 1.479*** | (1.28, 1.71) |
  Hypertension | 1.106*** | (1.05, 1.16) | 1.106*** | (1.05, 1.16) | 1.319*** | (1.18, 1.47) | 1.320*** | (1.18, 1.47) |
  Heart disease | 1.310*** | (1.22, 1.40) | 1.310*** | (1.23, 1.40) | 1.229* | (1.04, 1.45) | 1.231* | (1.04, 1.45) |
  Asthma | 1.503*** | (1.39, 1.62) | 1.505*** | (1.39, 1.63) | 1.479*** | (1.21, 1.81) | 1.484*** | (1.22, 1.81) |
  Cancer | 1.219*** | (1.10, 1.36) | 1.221*** | (1.10, 1.36) | 1.298 | (0.99, 1.70) | 1.302 | (0.99, 1.71) |
  Depression | 1.211*** | (1.11, 1.32) | 1.211*** | (1.11, 1.32) | 1.404** | (1.15, 1.72) | 1.404** | (1.15, 1.72) |
 Proxy respondent (versus no) | 0.945** | (0.91, 0.98) | 0.946** | (0.91, 0.98) | 1.042 | (0.95, 1.14) | 1.040 | (0.95, 1.14) |
 Month (versus July) | ||||||||
  August | 1.408*** | (1.37, 1.45) | 1.409*** | (1.37, 1.45) | 1.584*** | (1.48, 1.69) | 1.585*** | (1.48, 1.69) |
  September | 1.795*** | (1.74, 1.85) | 1.797*** | (1.74, 1.85) | 2.121*** | (1.98, 2.27) | 2.124*** | (1.98, 2.28) |
  October | 2.167*** | (2.10, 2.24) | 2.169*** | (2.10, 2.24) | 2.579*** | (2.40, 2.77) | 2.581*** | (2.40, 2.77) |
  November | 2.450*** | (2.37, 2.53) | 2.453*** | (2.37, 2.53) | 2.909*** | (2.70, 3.13) | 2.912*** | (2.70, 3.14) |
 Constant | 0.001*** | (0.00, 0.01) | 0.007*** | (0.00, 0.01) | 0.000*** | (0.00, 0.00) | 0.001*** | (0.00, 0.00) |
 Random ID | 6.577 | (6.44, 6.72) | 6.571 | (6.43, 6.71) | 10.651 | (10.25, 11.07) | 10.648 | (10.25, 11.07) |